<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">SS</journal-id><journal-title-group><journal-title>Surgical Science</journal-title></journal-title-group><issn pub-type="epub">2157-9407</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ss.2018.911048</article-id><article-id pub-id-type="publisher-id">SS-88722</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Hypochlorous Acid for Septic Abdominal Processes Using a Unique Negative Pressure Wound Therapy System: A Pilot Study
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Marc</surname><given-names>R. Matthews</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Asia</surname><given-names>N. Quan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Anushi</surname><given-names>R. Shah</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Carmen</surname><given-names>I. Tugulan</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Beshoy</surname><given-names>A. Nashed</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ross</surname><given-names>F. Goldberg</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Paola</surname><given-names>G. Pieri</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Luis</surname><given-names>G. Fernandez</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Areta</surname><given-names>Kowal-Vern</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kevin</surname><given-names>N. Foster</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff5"><addr-line>Division of Trauma Surgery/Surgical Critical Care, Trauma Surgical Critical Care Unit, Christus Trinity Mother Frances Health System, Tyler, TX, USA</addr-line></aff><aff id="aff3"><addr-line>Department of Surgery, Maricopa Integrated Health Systems, Phoenix, AZ, USA</addr-line></aff><aff id="aff4"><addr-line>Department of Surgery, Mountain Vista Medical Center, Phoenix, AZ, USA</addr-line></aff><aff id="aff2"><addr-line>Burn/Trauma Critical Care, Department of Inpatient Pharmacy, Maricopa Integrated Health Systems, Phoenix, AZ, USA</addr-line></aff><aff id="aff1"><addr-line>The Arizona Burn Center, Department of Surgery, Maricopa Integrated Health Systems, Phoenix, AZ, USA</addr-line></aff><aff id="aff6"><addr-line>Department of Research, The Arizona Burn Center, Maricopa Integrated Health Systems, Phoenix, AZ, USA</addr-line></aff><pub-date pub-type="epub"><day>02</day><month>11</month><year>2018</year></pub-date><volume>09</volume><issue>11</issue><fpage>412</fpage><lpage>421</lpage><history><date date-type="received"><day>25,</day>	<month>September</month>	<year>2018</year></date><date date-type="rev-recd"><day>23,</day>	<month>November</month>	<year>2018</year>	</date><date date-type="accepted"><day>26,</day>	<month>November</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Septic open abdomens occur in trauma, burn and surgery. Currently, multiple concentrations of hypochlorous acid solutions have effectively decreased the microbiotic burden in wounds. We hypothesized that Vashe
  <sup>&#174;</sup>, a neutral hypochlorous acid solution (V-HOCL), would be safe as an intraperitoneal irrigation or washout disinfectant for septic open abdomens utilizing negative pressure wound therapy. 
  Methods: This is a retrospective observational review of patients who required delayed abdominal closures after exploratory laparotomies. Group A (n = 8) had cyclical V-HOCL irrigation to their open abdomens combining Abthera
  <sup>TM</sup> and V.A.C. Dressing System for negative pressure wound therapy with irrigation (NPWT-i) and Group B (n = 9) had intra-abdominal V-HOCL washouts. 
  Results: Fifty percent of both groups had either septic or hemorrhagic shock on admission. Compared to Group B, Group A patients were older (median 50 vs 37 years), and had a median hospitalization of 28 vs 8 days, 4 times as many operations, more acute renal failure and co-morbidities. No statistically significant differences were detected be-tween the two treatment methods with the V-HOCL delivery and removal. 
  Conclusion: There were no episodes of electrolyte imbalance, hypotension, hypertension, anaphylaxis, hemorrhage, visceral injury or systemic toxicity. V-HOCL with/without NPWT-i irrigation was a safe modality and tolerated well in this study.
 
</p></abstract><kwd-group><kwd>Abthera&lt;sup&gt;TM&lt;/sup&gt;</kwd><kwd> Hypochlorous Acid</kwd><kwd> Negative Pressure Wound  Therapy-Irrigation (NPWT-i)</kwd><kwd> Septic Abdomen</kwd><kwd> Temporary Abdominal  Closure (TAC)</kwd><kwd> V.A.C. VeraFlo&lt;sup&gt;TM&lt;/sup&gt;</kwd><kwd> Vashe&lt;sup&gt;&amp;#174;&lt;/sup&gt;</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Temporary Abdominal Closure (TAC) has become standard surgical management of the open abdomen in the setting of septic shock, coagulopathy, and damage control laparotomy. Negative pressure wound therapy (NPWT) evacuates intraabdominal fluid and purulent drainage during resuscitative measures and protects the exposed viscera for critically ill patients with open abdomens [<xref ref-type="bibr" rid="scirp.88722-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.88722-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.88722-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.88722-ref4">4</xref>] . New uses for NPWT include irrigation or washout TAC methods to reduce microbial contamination and promote healing [<xref ref-type="bibr" rid="scirp.88722-ref5">5</xref>] .</p><p>In 1916, Fraser and Bates published successful treatment of appendiceal abscesses, viscus-perforating bullet wounds, and peritonitis with an antiseptic intra-abdominal washout using a 0.5% hypochlorous acid in normal saline (EUSOL) [<xref ref-type="bibr" rid="scirp.88722-ref6">6</xref>] .</p><p>In their 6-month war experience, they were able to decontaminate wounds of gas gangrene, compound fractures, joints, skull fractures, chest, and abdominal surgery with EUSOL. Their report noted that hypochlorous acid as “Eusol” was a potent disinfectant in their experience, and helped their soldiers to survive. They performed rabbit experiments to confirm that a hypochlorous acid solution washout, (leaving some solution in situ upon closure), was without deleterious effect (such as adhesions) [<xref ref-type="bibr" rid="scirp.88722-ref6">6</xref>] . Hypochlorous (HOCL) acid is a beneficial wound cleanser. It reduces the prokaryotic organism burden to 10<sup>−2</sup> power, while normal saline only reduces it to the 10<sup>−5</sup> power [<xref ref-type="bibr" rid="scirp.88722-ref7">7</xref>] . One hundred three years later, it was used intra-abdominally again as an irrigant with NPWT-I documented in the literature as a case report [<xref ref-type="bibr" rid="scirp.88722-ref8">8</xref>] . This study aimed to evaluate the use of Vashe<sup>&#210;</sup>, (SteadMed. Inc., Fort Worth, TX) (V-HOCL) as a simple washout or irrigant, utilizing NPWT-i: Abthera<sup>TM</sup> (Acelity, Inc, San Antonio, TX) and V.A.C. Dressing System<sup>TM</sup> (Acelity, Inc, San Antonio, TX) in acutely ill patients with septic open abdomens. We hypothesized that the use of V-HOCL would be safe to use as an intra-abdominal washout and irrigation in the short and long term open septic abdomens. In addition, we hypothesize that V-HOCL is not hazardous to the peritoneum or serosal surfaces of the abdominal organs.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Sample Population</title><p>This was an observational pilot study (January 2017-January 2018) to determine the feasibility of utilizing V-HOCL as a washout or irrigant for septic open abdomens. It entailed a retrospective chart review in patients treated with V-HOCL either as a washout for gunshot wounds, peritonitis, perforated viscus and damage control laparotomy resolution, or as an irrigant for patients who required longer term irrigation of their septic abdomens utilizing negative pressure wound therapy. The protocol encompassed trauma, burn and general surgery services. Hypochlorous acid as a disinfectant had not been reported in septic open abdomens since 1916. This was a preliminary trial use of hypochlorous acid in surgical patients with either open abdomens who required abdominal washouts during surgery or who required more intensive irrigation treatment with negative pressure wound therapy for a longer term. Inclusion criteria were determined by the operating surgeon based on acute illness factors in the operating room. There were 17 patients in two groups: Group A (n = 8) with V-HOCL irrigation using two devices that have been denoted as off-label when used together: Abthera<sup>TM</sup> (Acelity, Inc, San Antonio, TX) and V.A.C. Dressing System<sup>TM</sup> (Acelity, Inc, San Antonio, TX), (patients requiring NPWT-i).Group B (n = 9) had an open abdomen with intra-abdominal V-HOCL washout and closure of the abdomen within 24 to 48 hours (mainly trauma patients). The Maricopa Integrated Health System Institutional Review Board approved this pilot study.</p></sec><sec id="s2_2"><title>2.2. Vashe<sup>&#210;</sup> (V-HOCL) Wound Cleansing Solution [<xref ref-type="bibr" rid="scirp.88722-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.88722-ref10">10</xref>]</title><p>Hypochlorous acid is usually formed as a final step in the oxidative burst pathway, killing pathogens within the neutrophil. It is a natural product biochemically created by the innate human immune system and well-tolerated in human tissues. Vashe<sup>&#210;</sup> (V-HOCL) Wound Cleansing Solution (SteadMed. Inc., Fort Worth, TX) consists of normal saline with 0.033% hypochlorous acid added as a preservative. It has a neutral pH of 5.5 (range 4 - 6) compatible with that of the skin and is less toxic than chlorine or sodium hypochlorite. Peritoneal fluid pH is in the range of 7.5 - 8.0. Currently, V-HOCL is used to cleanse wounds, irrigate foreign materials, and disrupt biofilm. Since it is approved for external use only, V-HOCL was used off label in this study. In view of the literature report that a stronger hypochlorous acid disinfectant (EUSOL, 0.5%) was used successfully without deleterious effect on the patients, the current weaker solution (0.033%) was considered reasonable as an intraabdominal disinfectant for this study [<xref ref-type="bibr" rid="scirp.88722-ref6">6</xref>] .<sup> </sup></p></sec><sec id="s2_3"><title>2.3. ABTHERA<sup>TM</sup> Therapy System [<xref ref-type="bibr" rid="scirp.88722-ref11">11</xref>]</title><p>ABTHERA<sup>TM</sup> Therapy System (Acelity<sup>TM</sup>, San Antonio, TX) is designed to remove peritoneal fluid, reduce edema, minimize fascial retraction, loss of abdominal domain, and protect abdominal contents. It allows quick access for re-entry and does not require sutures for placement. This is the set up for NPWT, providing the covering and sponge layers over the open abdomen contents for this procedure (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p></sec><sec id="s2_4"><title>2.4. V.A.C. Dressing System</title><p>The V.A.C. Dressing System (Acelity<sup>TM</sup>, San Antonio, TX) uses a single unit delivery and suction system that combines the benefits of VAC therapy with automated topical wound solution distribution and removal (<xref ref-type="fig" rid="fig2">Figure 2</xref>). It has two tubes bound together (<xref ref-type="fig" rid="fig1">Figure 1</xref>(e)). One lumen is for the volumetric instillation of irrigation fluid mostly on a wounded extremity or torso soft tissues, while the adjacent tubing, provides for the suction removal of that irrigation product. It is placed over the Abthera<sup>TM</sup> portion and through a hole in the VAC occlusive dressing which provides the connection for tube delivered inflow V-HOCL and outflow drainage (NPWT-i) as per the surgeon’s programmed settings (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Wolvos utilized this system in treating wounds with either a hypochlorous acid solution Microcyn<sup>&#210;</sup> (Oculus Innovative Sciences, Petaluna, CA) or Dakin’s Solution<sup>&#210;</sup> (Century Pharmaceuticals, Indianapolis, IN) [<xref ref-type="bibr" rid="scirp.88722-ref12">12</xref>] .<sup> </sup></p></sec><sec id="s2_5"><title>2.5. Procedure [<xref ref-type="bibr" rid="scirp.88722-ref8">8</xref>] <sup> </sup></title><p>Both groups had the immediate, standard abdominal washout and removal of succus entericus or stool with an initial one to three liters of normal saline. Group A proceeded with the Abthera<sup>TM</sup> device placement into each abdominal quadrant followed by an occlusive dressing and covered by the V.A.C. Dressing System<sup>TM</sup>. The combination of these two devices provided the best delivery of V-HOCL throughout the abdominal cavity with only one hole made in the occlusive dressing to accommodate the inflow and outflow tubing from the V.A.C.</p><p>Dressing System<sup>TM</sup>. This utilization of the two products together permitted the irrigation of the open toxic abdomen repeatedly as if going to the operating room every three hours for irrigation.</p><p>Each irrigation consisted of 500 ml of V-HOCL every 3 hours with a dwell time of 30 minutes for the instillation period. Group B had an intraabdominal V-HOCL washout at the end of the operation, which remained in the open abdomen for 15 to 30 seconds before suction removal and closure either immediately or within the next 24 to 48 hours.</p></sec><sec id="s2_6"><title>2.6. Statistical Analysis</title><p>Statistical Analysis was performed utilizing Statistica<sup>&#210;</sup> (StatSoft, Tulsa, OK) descriptive statistics with ANOVA-one way and chi-squared. Patient demographics included: sex, age, diagnosis, comorbidities, length of stay (LOS), systemic toxicities, anaphylaxis, pre and post treatment levels of CBC, chloride, lactate, pH, and bicarbonate; renal failure, anastomotic breakdown, adhesions, and mortality. A p value of &lt;0.05 was considered significant.</p></sec></sec><sec id="s3"><title>3. Results</title><p><xref ref-type="table" rid="table1">Table 1</xref> describes the demographic characteristics of Group A (NPWT-i compared</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Demographic characteristics</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Parameters</th><th align="center" valign="middle" >#</th><th align="center" valign="middle" >Group A (NPWT-i)</th><th align="center" valign="middle" >#</th><th align="center" valign="middle" >Group B (Washout)</th></tr></thead><tr><td align="center" valign="middle" >Age (years)</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >49.3 &#177; 14.6 (24 - 66, 50)</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >45.8 &#177; 16.3 (28 - 69, 37)</td></tr><tr><td align="center" valign="middle" >M/F</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >M4/F4</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >M6/F3</td></tr><tr><td align="center" valign="middle" >LOS (days)</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >27.1 &#177; 19.0 (3 - 60, 28)</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >14.0 &#177; 16.4 (3 - 56, 8)</td></tr><tr><td align="center" valign="middle" >Mortality (%)</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >50.0%</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Diagnosis</td><td align="center" valign="middle"  colspan="2"  ></td></tr><tr><td align="center" valign="middle" >Perforated Viscus (%)</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >38.5%</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >61.5%</td></tr><tr><td align="center" valign="middle" >*Other (%)</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >75.0%</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >25.0%</td></tr><tr><td align="center" valign="middle" >^Shock (%)</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >50.0%</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >50.0%</td></tr><tr><td align="center" valign="middle" >Renal Failure (#)</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >75% (6)</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >11.1% (1)</td></tr><tr><td align="center" valign="middle" >CRRT (#)</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >62.5% (5)</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >0</td></tr></tbody></table></table-wrap><p>Mean &#177; sd, (Range, Median); M/F = Male/Female. *Toxic Epidermal Necrolysis, Thermal Injury, Necrotizing Fasciitis; ^Septic or Hemorrhagic; NPWT-i = Negative Pressure Wound Therapy-Irrigation.</p><p>to Group B (Washout). Both groups tolerated V-HOCL washout/irrigations. Fifty percent of both groups were in either septic or hemorrhagic shock on admission. Group A had more severely ill patients (burns, necrotizing fasciitis, acute renal injury) versus mainly perforated viscus in Group B (Washout). Compared to Group B patients, Group A were older (median 50 vs 37 years), had a median hospitalization of 28 vs 8 days, 4 times as many operations, an increased frequency of acute renal failure (75% vs 11%), 63% required continuous renal replacement therapy, and an overall increase in co-morbidities. Diabetes, cardiac disease, COPD, renal failure, psychiatric disease, and heroin abuse were the most common co-morbidities. The patients tolerated the procedure well and did not undergo episodes of hypotension, hypertension, anaphylaxis, or systemic toxicity. There were four mortalities in Group A that were attributed to the initial diagnosis and not to the NPWT-i treatment, which was an incidental confounding factor regarding these deaths. Of significance, the two anastomotic breakdowns in Group A did not occur during the V-HOCL irrigations.</p><p>In <xref ref-type="table" rid="table2">Table 2</xref>, as expected, Group A had a longer irrigation exposure to V-HOCL with the intraabdominal NPWT-i, median 23 liters (range 7 to 47 liters), compared to Group B, median 3 liters (range 1 to 3 liters). <xref ref-type="table" rid="table3">Table 3</xref> shows the laboratory values pre- and post-washouts and irrigations. There were no statistically significant differences between the two treatment methods with V-HOCL delivery and removal. In both groups, the white blood cell count was decreased post-treatment, and serum chloride levels were slightly increased but within normal limits. Comparing Group A with Group B, pre-treatment hemoglobin was significantly decreased, (median 9.8 vs 12.6 g/dl, p &lt; 0.01) as were the platelets, (median 166 vs 312, p &lt; 0.047). There were no statistically significant differences between the two groups in lactate, pH, and CO<sub>2</sub> or HCO<sub>3</sub> pre- and post-washout and irrigation procedures.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Operative data</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Parameters</th><th align="center" valign="middle" >#</th><th align="center" valign="middle" >Group A (NPWT-i)</th><th align="center" valign="middle" >#</th><th align="center" valign="middle" >Group B (Washout)</th></tr></thead><tr><td align="center" valign="middle" >V-HOCL solution (Liters) Difference in fluid used p &lt; 0.01</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >22.5 &#177; 12.5 (7 - 47, 23)</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >2.5 &#177; 0.77 (1.0 - 3.0, 3.0)</td></tr><tr><td align="center" valign="middle" >V-HOCL Tx Time (Days)</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >4.9 &#177; 3.1 (1 - 11, 5)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >N/A</td></tr><tr><td align="center" valign="middle" >Operations (#)</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >5.4 &#177; 5.7 (2 - 19, 4)</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >2.2 &#177; 2.0 (1 - 7, 1)</td></tr><tr><td align="center" valign="middle" >*Abdomen Open (Days)</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >7.9 &#177; 7.4 (2 - 25, 5)</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >7.7 &#177; 7.4 (2 - 16, 5)</td></tr><tr><td align="center" valign="middle" >Anastomosis (#)</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >22.2% (2)</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Adhesions (#)</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >37.5% (3)</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >0</td></tr></tbody></table></table-wrap><p>Mean &#177; sd, (range, Median); no hemodialysis or anaphylaxis; NPWT-I = Negative pressure wound therapy-irrigation; Tx Time = Treatment Time; *the other 6 patients had their abdomens closed within 24 - 48 hours.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Laboratory values before and after irrigation and washout</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Parameters</th><th align="center" valign="middle" >#</th><th align="center" valign="middle" >Group A (NPWT-i)</th><th align="center" valign="middle" >#</th><th align="center" valign="middle" >Group B (Washout)</th></tr></thead><tr><td align="center" valign="middle" >Chloride PreOp *p &lt; 0.01</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >107.8 &#177; 3.6 (103 - 112, 108)</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >102.3 &#177; 5.2 (93 - 109,104)</td></tr><tr><td align="center" valign="middle" >Chloride PostOp</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >109.1 &#177; 3.9 (102 - 113, 110.5)</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >107.3 &#177; 4.1 (103 - 114, 107)</td></tr><tr><td align="center" valign="middle" >WBC PreOp</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >14.1 &#177; 10.7 (5.2 - 38.8, 11.7)</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >17.1 &#177; 7.0 (5.0 - 26.8, 17.1)</td></tr><tr><td align="center" valign="middle" >WBC PostOp</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >12.1 &#177; 6.6 (4.3 - 21.3, 13.2)</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >13.1 &#177; 7.4 (1.3 &#177; 22.9, 15.0)</td></tr><tr><td align="center" valign="middle" >Hgb PreOp *p &lt; 0.01</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >10.0&#177;2.4 (6.3 - 14.9, 9.8)</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >13.7 &#177; 3.1 (9.9 - 18.2, 12.6)</td></tr><tr><td align="center" valign="middle" >Hbg PostOp</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >10.7 &#177; 1.5 (8.5 - 13.7, 10.5)</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >12.0 &#177; 2.0 (9.3 - 16.1, 12)</td></tr><tr><td align="center" valign="middle" >Hct PreOp *p &lt; 0.01</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >27.1 &#177; 9.2 (10.9 - 42.8, 28.2)</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >39.6 &#177; 8.6 (27.6 - 53.7, 37.9)</td></tr><tr><td align="center" valign="middle" >Hct PostOp</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >31.8 &#177; 4.3 (25.8 - 39.3, 30.8)</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >35.1 &#177; 5.8 (27.5 - 46.5, 35.2)</td></tr><tr><td align="center" valign="middle" >Plt PreOp *p &lt; 0.047</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >182.9 &#177; 113.3 (51 - 403, 166)</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >331.6 &#177; 155 (189 - 687, 312)</td></tr><tr><td align="center" valign="middle" >Plt Post Op</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >182.5 &#177; 91.1 (68 - 361, 181)</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >247 &#177; 38 (203 - 207, 243)</td></tr></tbody></table></table-wrap><p>Mean &#177; sd, (range, Median); NPWT-I = Negative pressure wound therapy-irrigation; PreOp = Before procedure; PostOp = After procedure; Hgb = Hemoglobin; Hct = Hematocrit; Plt = Platelets.</p></sec><sec id="s4"><title>4. Discussion</title><p>In this retrospective observational pilot study, both short term and prolonged care with V-HOCL as an intraabdominal disinfectant for the open septic abdomen was safe and beneficial to use in the setting of trauma, burn and general surgery. In addition, V-HOCL was not hazardous to the peritoneum or serosal surfaces of the abdominal organs as a washout solution or irrigant with NPWT-i. This study confirmed the findings and recommendations of Fraser and Bates in 1916 for the use of HOCL acid in septic open abdomens [<xref ref-type="bibr" rid="scirp.88722-ref6">6</xref>] . There were no systemic toxicities noted or attributed to utilizing V-HOCL in a protocol requiring intermittent fluid irrigation and drainage for a period of days (Group A) or as an open abdomen surgical washout solution (Group B).</p><p>Except for documentation by Fraser and Bates [<xref ref-type="bibr" rid="scirp.88722-ref6">6</xref>] (over a century ago), and Matthews [<xref ref-type="bibr" rid="scirp.88722-ref8">8</xref>] , we were unable to find the use of any HOCL acid solution as an irrigant or washout of the open septic abdomen in the literature. HOCL acid solutions have been reported mainly as disinfectants for wounds at a risk for healing [<xref ref-type="bibr" rid="scirp.88722-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.88722-ref13">13</xref>] . Currently, NPWT has been a major player in the healing of surgical wounds.</p><p>Besides Matthews et al., there have been 3 reported studies between 2012 and 2017 utilizing NPWT-i for wounds at risk for healing, or septic abdomens [<xref ref-type="bibr" rid="scirp.88722-ref8">8</xref>] . Gabriel et al. reported 2 cases of deep wounds which benefited from V.A.C. VeraFlo<sup>TM</sup> Therapy with Prontosan<sup>&#210;</sup> (B. Braun Medical, Inc. Bethlehem, PA) and another case with normal saline [<xref ref-type="bibr" rid="scirp.88722-ref14">14</xref>] . Brinkert et al. used NPWT-i with normal saline on 131 diabetic and orthopedic wounds successfully [<xref ref-type="bibr" rid="scirp.88722-ref15">15</xref>] . Sibaja et al. documented normal saline irrigation in 48 patients with septic open abdomens in a controlled fashion in trauma and general surgery patients using NPWT-i [<xref ref-type="bibr" rid="scirp.88722-ref16">16</xref>] .</p><p>Limitations of this retrospective observational study were the small number of patients. Although there was a protocol for the use of V-HOCL with NPWT-i in Group A, Group B patients obtained standard abdominal washout procedures with V-HOCL at the discretion of the operating surgeon. Neither Group A nor B procedures provided information as to the distribution of the irrigant or washout into all abdominal quadrants. There was no protocol in place for a standardized collection of abdominal fluid or intraabdominal cultures at baseline, during treatment or post treatment. Ongoing studies in the medical center are using V-HOCL and assessing the microbiology of the peritoneal cavity before and after washout or irrigation with V-HOCL.</p></sec><sec id="s5"><title>5. Conclusion or Summary Statement</title><p>This pilot study has shown that Vashe<sup>&#210;</sup>, a 0.033% hypochlorous acid in normal saline solution is safe as a standard surgical intra-abdominal washout or NPWT-i irrigant using the combination of the Abthera<sup>TM</sup> device and V.A.C. Dressing System<sup>TM</sup> for septic open abdomens. In patients requiring an exploratory laparotomy and possibly an open abdomen for continuous irrigation or a single washout of the abdomen, these interventions may provide a benefit to the patient with a septic open abdomen.</p></sec><sec id="s6"><title>Funding</title><p>There was no funding for this Pilot Study.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>Each of the above listed authors declare that there are no conflicts of interest related to this manuscript, except for Marc R. Matthews, MD, Luis G. Fernandez, MD, who are surgical consultants for both Acelity, Inc., and SteadMed Medical, LLC.</p></sec><sec id="s8"><title>Cite this paper</title><p>Matthews, M.R., Quan, A.N., Shah, A.R., Tugulan, C.I., Nashed, B.A., Goldberg, R.F., Pieri, P.G., Fernandez, L.G., Kowal-Vern, A. and Foster, K.N. (2018) Hypochlorous Acid for Septic Abdominal Processes Using a Unique Negative Pressure Wound Therapy System: A Pilot Study. Surgical Science, 9, 412-421. https://doi.org/10.4236/ss.2018.911048</p></sec></body><back><ref-list><title>References</title><ref id="scirp.88722-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Navsaria, P., Nicol, A., Hudson, D., Cockill, J. and Smith, J. (2013) Negative Pressure Wound Therapy Management of the “Open Abdomen” Following Trauma: A Prospective Study and Systematic Review. World Journal of Emergency Surgery, 8, 4. https://doi.org/10.1186/1749-7922-8-4</mixed-citation></ref><ref id="scirp.88722-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Lima, R.V.K.S., Coltro, P.S. and Farina, J.A. (2017) Negative Pressure Therapy for the Treatment of Complex Wounds. Revista do Colégio Brasileiro de Cirurgi&amp;#245;es, 44, 81-93. https://doi.org/10.1590/0100-69912017001001</mixed-citation></ref><ref id="scirp.88722-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Roberts, D.J., Zygun, D.A., Grendar, J., et al. (2012) Negative-Pressure Wound Therapy for Critically Ill Adults with Open Abdominal Wounds: A Systematic Review. Journal of Trauma and Acute Care Surgery, 73, 629-639. https://doi.org/10.1097/TA.0b013e31825c130e</mixed-citation></ref><ref id="scirp.88722-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Lessing, M.C., James, R.B. and Ingram, S.C. (2013) Comparison of the Effects of Different Negative Pressure Wound Therapy Modes—Continuous, Noncontinous and with Instillation—On Porcine Excisional Wounds. Eplasty, 13, e51.</mixed-citation></ref><ref id="scirp.88722-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">D’Hondt, M., D’Haeninck, A., Derye, L., et al. (2011) Can Vacuum-Assisted Closure and Instillation Therapy (VAC-Instill&lt;sup&gt;&amp;#174;&lt;/sup&gt; Therapy) Play a Role in the Treatment of the Infected Open Abdomen? Techniques in Coloproctology, 15, 75-77. https://doi.org/10.1007/s10151-010-0662-4</mixed-citation></ref><ref id="scirp.88722-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Fraser, J. and Bates, H.J. (1916) The Surgical and Antiseptic Values of Hypochlorous Acid (EUSOL). Journal of the Royal Army Medical Corps, 27, 79-84.</mixed-citation></ref><ref id="scirp.88722-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Hiebert, J.M. and Robson, M.C. (2016) The Immediate and Delayed Post-Debridement Effects on Tissue Bacterial Wound Counts of Hypochlorous Acid versus Saline Irrigation in Chronic Wounds. Eplasty. 16, e32.</mixed-citation></ref><ref id="scirp.88722-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Matthews, M.R., Quan, A.N., Weir, A.S., Foster, K.N. and Caruso, D.M. (2018) Temporary Abdominal Closure Combined with an Irrigating System Utilizing Hypochlorous Acid Solution to Decrease Abdominal Mucopurulence. Eplasty, 18, e12.</mixed-citation></ref><ref id="scirp.88722-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Couch, K.S., Miller, C., Cnossen, L.A., Richey, K.J. and Guinn, S.J. Non-Cytotoxic Wound Bed Preparation: Vashe Hypochlorous Acid Wound Cleansing Solution. Wound Source White Paper. http://www.steadmed.com/wp-content/uploads/2016/11/Vashe-Wound-Cleansing-Final-final.pdf</mixed-citation></ref><ref id="scirp.88722-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Robson, M.C., Payne, W.G., Ko, F., et al. (2007) Hypochlorous Acid as a Potential Wound Care Agent: Part II, Stabilized Hypo-Chlorous Acid: Its Role in Decreasing Tissue Bacterial Bioburden and Overcoming the Inhibition of Infection on Wound Healing. Journal of Burns and Wounds, 6, 80-90.</mixed-citation></ref><ref id="scirp.88722-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Roberts, D.J., Jenne, C.N., Ball, C.G., Tiruta, C., Lèger, C., et al. (2013) Efficacy and Safety of Active Negative Pressure Peritoneal Therapy for Reducing the Systemic Inflammatory Response after Damage Control Laparotomy (the Intra-Peritoneal Vacuum Trial): Study Protocol for Randomized Controlled Trial. Trials, 14, 141. http://www.trialsjournal.com/content/14/1/141 https://doi.org/10.1186/1745-6215-14-141</mixed-citation></ref><ref id="scirp.88722-ref12"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wolvos</surname><given-names> T. </given-names></name>,<etal>et al</etal>. (<year>2013</year>)<article-title>The Use of Negative Pressure Wound Therapy with an Automated, Volumetric Fluid Administration: An Advancement in Wound Care</article-title><source> Wounds</source><volume> 25</volume>,<fpage> 75</fpage>-<lpage>83</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.88722-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Strohal, R., Mittlb&amp;ouml;ck, M. and H&amp;auml;mmerle, G. (2018) The Management of Critically Colonized and Locally Infected Leg Ulcers with an Acid-Oxidizing Solution: A Pilot Study. Advances in Skin &amp; Wound Care, 31, 163-171. https://doi.org/10.1097/01.ASW.0000530687.23867.bd</mixed-citation></ref><ref id="scirp.88722-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Gabriel, A. (2012) Integrated Negative Pressure Wound Therapy System with Volumetric Automated Instillation in Wounds at Risk for Compromised Healing. International Wound Journal, 9, 25-31. https://doi.org/10.1111/j.1742-481X.2012.01014.x</mixed-citation></ref><ref id="scirp.88722-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Brinkert, D., Ali, M., Naud, M., et al. (2013) Negative Pressure Wound Therapy with Saline Instillation: 131 Patient Case Series. International Wound Journal, 10, 56-60. https://doi.org/10.1111/iwj.12176</mixed-citation></ref><ref id="scirp.88722-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Sibaja, P., Sanchez, A., Villegas, G., et al. (2017) Management of the Open Abdomen Using Negative Pressure Wound Therapy with Instillation in Severe Abdominal Sepsis: A Review of 48 Cases in Hospital Mexico, Costa Rica. International Journal of Surgery Case Reports, 30, 26-30. https://doi.org/10.1016/j.ijscr.2016.11.024</mixed-citation></ref></ref-list></back></article>